FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
Cigna Sues Federal Trade Commission Over ‘Defamatory’ Report
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes pharmacy benefit managers and asked the court to order the agency to retract it.
High Insulin Prices Spur a Federal Lawsuit Against Three Pharmacy Benefit Managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
FTC Sues CVS Health, Cigna And United Health Group For Inflating Insulin Prices
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's
FTC Sues CVS, Cigna, UnitedHealth Over Insulin Costs
Bloomberg's Tyler Kendall breaks down the latest in the suit accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin. (Source: Bloomberg)
FTC Sues Pharmacy Middlemen For Allegedly Inflating Insulin Prices
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin.
Cigna Group stock outperforms competitors despite losses on the day
Cigna Group closed $14.69 short of its 52-week high ($370.83), which the company reached on September 16th.
Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'
Cigna Healthcare's divestiture of low-margin Medicare businesses will allow focus on employer-sponsored plans. Learn more on ...
bovnews3d
Why Did Cigna Group (CI) Stock Plunge -0.52% Last Week?
Cigna Group (CI) stock saw a decline, ending the day at $356.23 which represents a decrease of $-10.62 or -2.89% from the prior close of $366.85. The stock opened at $364.66 and touched a low of $354.
Cigna Group stock underperforms Wednesday when compared to competitors
Shares of Cigna Group CI slid 0.24% to $355.39 Wednesday, on what proved to be an all-around poor trading session for the ...
Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
CI benefits from improved premiums resulting from an extensive customer base. Buyouts and adequate operating cash flows are ...
Hosted on MSN9mon
Cigna raises stock buyback by $10 billion, will reportedly drop bid to buy Humana
Managed-care provider Cigna Group on Sunday announced a massive stock buyback, amid a report that it has abandoned its bid to buy rival Humana Inc. Citing sources familiar with the matter ...
Here's How Much You Would Have Made Owning Cigna Stock In The Last 10 Years
Cigna CI has outperformed the market over the past 10 years by 3.83% on an annualized basis producing an average annual ...
Top Stock Movers Now: Intel, Microsoft, Amazon, Cigna, and More
U.S. equities were higher around midday as August retail sales were higher than anticipated and the Fed began its two-day ...
Yahoo Finance10h
The Cigna Group (CI)
The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially ...
Cigna's Express Scripts Sues FTC, Demands Withdrawal Of PBM Report; Stock Down
Express Scripts by Evernorth, a unit of Cigna Group (CI), Tuesday said it has filed a lawsuit against the Federal Trade Commission or ...